Shields AE - Search Results

1

Translating basic science to improve pharmacotherapy for nicotine dependence.

Phillips JM, Siegel SJ, Shields AE, Patterson F, Gould TJ, Strasser AA, Ray R, Pinto A, Audrain-McGovern J, Rukstalis M, Perkins KA, Blendy JA, Lerman C. Phillips JM, et al. Among authors: shields ae. Nicotine Tob Res. 2007 Nov;9 Suppl 4:S583-98. doi: 10.1080/14622200701691755. Nicotine Tob Res. 2007. PMID: 18067034 Review.

2

Translating emerging research on the genetics of smoking into clinical practice: ethical and social considerations.

Shields A, Lerman C, Sullivan P. Shields A, et al. Nicotine Tob Res. 2004 Aug;6(4):675-88. doi: 10.1080/14622200410001734058. Nicotine Tob Res. 2004. PMID: 15370164 Review.

3

Transdisciplinary science applied to the evaluation of treatments for tobacco use.

Baker TB, Hatsukami DK, Lerman C, O'Malley SS, Shields AE, Fiore MC. Baker TB, et al. Among authors: shields ae. Nicotine Tob Res. 2003 Dec;5 Suppl 1:S89-99. doi: 10.1080/14622200310001625564. Nicotine Tob Res. 2003. PMID: 14668089 Review.

4

Pharmacogenetics and nicotine addiction treatment.

Munafò MR, Shields AE, Berrettini WH, Patterson F, Lerman C. Munafò MR, et al. Among authors: shields ae. Pharmacogenomics. 2005 Apr;6(3):211-23. doi: 10.1517/14622416.6.3.211. Pharmacogenomics. 2005. PMID: 16013953 Review.

5

Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial.

Schnoll RA, Patterson F, Wileyto EP, Heitjan DF, Shields AE, Asch DA, Lerman C. Schnoll RA, et al. Among authors: shields ae. Ann Intern Med. 2010 Feb 2;152(3):144-51. doi: 10.7326/0003-4819-152-3-201002020-00005. Ann Intern Med. 2010. PMID: 20124230 Free PMC article. Clinical Trial.

6

Which adolescents are most receptive to tobacco industry marketing? implications for counter-advertising campaigns.

Audrain-McGovern J, Tercyak KP, Shields AE, Bush A, Espinel CF, Lerman C. Audrain-McGovern J, et al. Among authors: shields ae. Health Commun. 2003;15(4):499-513. doi: 10.1207/S15327027HC1504_07. Health Commun. 2003. PMID: 14527869

7

Genetic testing for cancer susceptibility: the promise and the pitfalls.

Lerman C, Shields AE. Lerman C, et al. Among authors: shields ae. Nat Rev Cancer. 2004 Mar;4(3):235-41. doi: 10.1038/nrc1301. Nat Rev Cancer. 2004. PMID: 14993905 Review. No abstract available.

8

Primary care physicians' willingness to offer a new genetic test to tailor smoking treatment, according to test characteristics.

Shields AE, Levy DE, Blumenthal D, Currivan D, McGinn-Shapiro M, Weiss KB, Yucel R, Lerman C. Shields AE, et al. Nicotine Tob Res. 2008 Jun;10(6):1037-45. doi: 10.1080/14622200802087580. Nicotine Tob Res. 2008. PMID: 18584467 Free PMC article.

9

Smoking cessation treatment by primary care physicians: An update and call for training.

Schnoll RA, Rukstalis M, Wileyto EP, Shields AE. Schnoll RA, et al. Among authors: shields ae. Am J Prev Med. 2006 Sep;31(3):233-9. doi: 10.1016/j.amepre.2006.05.001. Epub 2006 Jul 24. Am J Prev Med. 2006. PMID: 16905034

10

Smoking cessation treatment: pharmacogenetic assessment.

Munafò MR, Lerman C, Niaura R, Shields AE, Swan GE. Munafò MR, et al. Among authors: shields ae. Curr Opin Mol Ther. 2005 Jun;7(3):202-8. Curr Opin Mol Ther. 2005. PMID: 15977416 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

96 results

Search Page